Germline HOXB13 G84E mutation carriers and risk to twenty common types of cancer: results from the UK Biobank - PubMed

Germline HOXB13 G84E mutation carriers and risk to twenty common types of cancer: results from the UK Biobank - PubMed

Germline HOXB13 G84E mutation carriers and risk to twenty common types of cancer: results from the UK Biobank

Jun Wei 1, Zhuqing Shi 1, Rong Na 1, Chi-Hsiung Wang 1, W Kyle Resurreccion 1, S Lilly Zheng 1, Peter J Hulick 2, Kathleen A Cooney 3, Brian T Helfand 1, William B Isaacs 4, Jianfeng Xu 5

Affiliations 

• PMID: 32830201
 
• DOI: 10.1038/s41416-020-01036-8

Abstract

Germline HOXB13 G84E mutation has been consistently associated with prostate cancer (PCa) risk, but its association with other cancers is controversial. We systematically tested its association with the 20 most common cancer types in subjects from the UK Biobank. The G84E mutation was found in 1,545 (0.34%) of 460,224 participants of European ancestry. While mutation status did not associate with cancer risk in females, it was significantly associated with increased risk in males; odds ratio (OR) (95% confidence interval) for overall cancer diagnosis was 2.19 (1.89-2.52), P = 2.5E-19. The association remained after excluding PCa; OR = 1.4 (1.16-1.68), P = 0.003, suggesting association with other cancers. Indeed, suggestive novel associations were found for two other cancer types; rectosigmoid cancer, OR = 2.25 (1.05-4.15), P = 0.05 and non-melanoma skin cancer (NMSC), OR = 1.40 (1.12-1.74), P = 0.01. For NMSC, the association was found only in basal cell carcinoma, OR = 1.37 (1.07-1.74), P = 0.03. These findings have potential clinical utility for genetic counselling regarding HOXB13.

Similar articles

• The HOXB13 G84E Mutation Is Associated with an Increased Risk for Prostate Cancer and Other Malignancies.

  Beebe-Dimmer JL, Hathcock M, Yee C, Okoth LA, Ewing CM, Isaacs WB, Cooney KA, Thibodeau SN.Cancer Epidemiol Biomarkers Prev. 2015 Sep;24(9):1366-72. doi: 10.1158/1055-9965.EPI-15-0247. Epub 2015 Jun 24.PMID: 26108461 Free PMC article.
• A population-based assessment of germline HOXB13 G84E mutation and prostate cancer risk.

  Karlsson R, Aly M, Clements M, Zheng L, Adolfsson J, Xu J, Grönberg H, Wiklund F.Eur Urol. 2014 Jan;65(1):169-76. doi: 10.1016/j.eururo.2012.07.027. Epub 2012 Jul 20.PMID: 22841674
• Prevalence of the HOXB13 G84E germline mutation in British men and correlation with prostate cancer risk, tumour characteristics and clinical outcomes.

  Kote-Jarai Z, Mikropoulos C, Leongamornlert DA, Dadaev T, Tymrakiewicz M, Saunders EJ, Jones M, Jugurnauth-Little S, Govindasami K, Guy M, Hamdy FC, Donovan JL, Neal DE, Lane JA, Dearnaley D, Wilkinson RA, Sawyer EJ, Morgan A, Antoniou AC, Eeles RA; UK Genetic Prostate Cancer Study Collaborators, and the ProtecT Study Group.Ann Oncol. 2015 Apr;26(4):756-761. doi: 10.1093/annonc/mdv004. Epub 2015 Jan 16.PMID: 25595936
• Germline homeobox B13 (HOXB13) G84E mutation and prostate cancer risk in European descendants: a meta-analysis of 24,213 cases and 73, 631 controls.

  Shang Z, Zhu S, Zhang H, Li L, Niu Y.Eur Urol. 2013 Jul;64(1):173-6. doi: 10.1016/j.eururo.2013.03.007. Epub 2013 Mar 14.PMID: 23518396 Review. No abstract available.
• Dysregulation of the homeobox transcription factor gene HOXB13: role in prostate cancer.

  Decker B, Ostrander EA.Pharmgenomics Pers Med. 2014 Aug 5;7:193-201. doi: 10.2147/PGPM.S38117. eCollection 2014.PMID: 25206306 Free PMC article. Review.